Advanced glycation end products modulate transcriptional regulation in mesangial cells

Kidney Int. 1996 Oct;50(4):1166-72. doi: 10.1038/ki.1996.424.

Abstract

Advanced glycation end products (AGEs) stimulate synthesis of extracellular matrix (ECM) in a receptor-mediated manner on mesangial cells. In the present study, we examined the transcriptional regulation of the gene for type IV collagen [(IV)collagen], which is one of the major components of mesangial sclerosis, after stimulation of AGEs on mesangial cells. The methylation pattern of the promoter/enhancer region of (IV)collagen gene was similar in AGE-treated and control cells. AGEs significantly increased the transcriptional activity of the (IV)collagen gene, as measured by transient transfection assays using the reporter gene construct containing (IV)collagen promoter/enhancer and the chloramphenicol acetyltransferase gene. AGEs also increased smooth muscle alpha-actin mRNA levels as well as its transcriptional activity. Nuclear factor binding of the promoter of (IV)collagen gene was stimulated by AGEs. Furthermore, AGEs dramatically decreased the mRNA levels of (IV)collagen promoter binding protein (MSW), a larger subunit of DNA replication complex, AP1. These results suggest that AGEs increase expression of (IV)collagen gene by modulating the levels of promoter binding proteins. These transcriptional events may play a critical role in ECM accumulation in response to AGEs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / genetics
  • Animals
  • Base Sequence
  • Cells, Cultured
  • Collagen / genetics*
  • DNA Methylation
  • Gene Expression Regulation*
  • Glycation End Products, Advanced / pharmacology*
  • Kidney Glomerulus / physiology
  • Mice
  • Mice, Inbred C57BL
  • RNA, Messenger / analysis
  • Transcriptional Activation
  • Transfection

Substances

  • Actins
  • Glycation End Products, Advanced
  • RNA, Messenger
  • Collagen